3BBLACKBIO vs DRAGARWQ: Stock Comparison

3B Blackbio DX Ltd vs Dr Agarwals Eye Hospital Ltd

Live data: 28 July 2026, 4:08 PM IST • Source: NSE and company filings

Dr Agarwals Eye Hospital Ltd is the larger company by market capitalisation. 3B Blackbio DX Ltd shows a lower P/E, a higher dividend yield and lower leverage, while Dr Agarwals Eye Hospital Ltd shows a higher ROE. These are relative readings on individual metrics — weigh valuation against growth, margins, leverage and capital efficiency rather than treating any single number as decisive.

Side-by-side comparison of 3B Blackbio DX Ltd and Dr Agarwals Eye Hospital Ltd on live price, valuation, growth, profitability, leverage and quarterly shareholding. Highlighted values mark the more favourable of the two on that metric's usual reading; a single metric is never the full story.

On standard readings, 3BBLACKBIO is more favourable on 9 of 13 scored metrics and DRAGARWQ on 2These counts are context-free and are not an overall rating.

Key Differences

Market Cap
DRAGARWQ is the larger company
₹2,436 Cr vs ₹1,098 Cr
P/E Ratio
3BBLACKBIO has a lower P/E
19x vs 34.7x
P/B Ratio
3BBLACKBIO has a lower P/B
3.43x vs 7.02x
EPS
DRAGARWQ has higher earnings per share
₹145 vs ₹68.3
Dividend Yield
3BBLACKBIO has a higher dividend yield
0.34% vs 0.13%
Qtr Sales Growth
3BBLACKBIO has stronger quarterly sales growth
57.5% vs 20.2%
Qtr Profit Growth
3BBLACKBIO has stronger quarterly profit growth
13.8% vs 1.56%
ROE
DRAGARWQ has a higher ROE
25.2% vs 19.8%

Each difference is a single, relative reading — StockeZee does not name an overall winner.

Price

Metric3BBLACKBIODRAGARWQ
Live Price₹1,298.8₹5,052
Day Change0.5%0.21%
Volume10,694485
52-Week High₹1,441.5₹6,059.7
52-Week Low₹1,085₹4,600
Distance from 52W High-9.9%-16.63%

Valuation

Metric3BBLACKBIODRAGARWQ
Market Cap₹1,098 Cr₹2,436 Cr
P/E Ratio19x34.7x
P/B Ratio3.43x7.02x
EPS₹68.3₹145
Book Value₹378₹717
Dividend Yield0.34%0.13%

Growth

Metric3BBLACKBIODRAGARWQ
Revenue Growth (TTM YoY)0%0%
EPS Growth (TTM YoY)0%0%
Qtr Sales Growth57.5%20.2%
Qtr Profit Growth13.8%1.56%

Profitability & Leverage

Metric3BBLACKBIODRAGARWQ
ROE19.8%25.2%
ROCE25.5%17.4%
Net Margin42.23%14.89%
Operating Margin40%30.9%
Debt to Equity0.01x0.94x

Shareholding

As of Mar 2026 • change vs previous quarter
Metric3BBLACKBIODRAGARWQ
Promoter Holding38.46%72.67%
FII Holding2.57%2.2% 0.38 pp
DII Holding1.98% 0.1 pp2.12% 0.24 pp
Public Holding54.51% 0.23 pp23% 0.15 pp

How to Read This Comparison

Valuation ratios (P/E, P/B) use the latest consolidated figures where available; growth numbers compare against the same period last year; shareholding percentages come from the most recent quarterly filings, with the change shown against the prior quarter. A "more favourable" highlight is relative between these two companies only — it is not a rating, a recommendation, or a comparison against the wider sector. Rows with no reported data for either company are hidden rather than shown empty.

Deep-dive each company on its stock page for quarterly results, technicals, filings and the full peer set: 3B Blackbio DX Ltd and Dr Agarwals Eye Hospital Ltd.

Data source: NSE and company filings via StockeZee. This comparison is informational — it is not investment advice, and StockeZee is not a SEBI-registered investment adviser.